40 results
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
, represents an important vote of confidence from the investment community. The potential of GTX-104 as an improvement over the current standard of care in aSAH
8-K
ip96f4j
11 May 23
Departure of Directors or Certain Officers
4:50pm
424B5
18cz93jaqnjm8ra29
10 Nov 21
Prospectus supplement for primary offering
7:23am
424B3
afnvu6
15 Jul 21
Prospectus supplement
4:45pm
S-4
gb6yir
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
10-K
cqudl0zvkznspqzlh 33
29 Jun 20
Annual report
4:02pm